Intel Is Rocketing Higher on Reports That It May Partner With Apple. Should You Buy the Stock After an Incredible 175% Run This Year?

Intel shares are up 175% this year and rose nearly 13% intraday on reports it may become Apple’s main chip manufacturer for U.S. devices, a potential step forward for Intel’s turnaround. The article also cites Intel CEO Lip-Bu Tan saying CPUs are reentering the center of the AI stack, reinforcing the bullish AI narrative. No deal has been finalized, so the news is supportive but still speculative.

Analysis

The market is starting to price Intel less as a cyclical PC/server supplier and more as a strategic domestic foundry option, which is a very different valuation regime. If Apple engagement is real, the second-order benefit is not just headline revenue: it would validate Intel’s manufacturing roadmap with a marquee customer, lowering perceived execution risk and potentially compressing the discount to TSMC-only supply chains. That said, the market is likely front-loading a lot of the policy optionality before any wafer ever ships, so near-term upside may be driven more by narrative than by fundamental contribution.

The key competitive spillover is on TSM and, to a lesser extent, other Asia-heavy suppliers: even a partial Apple allocation to U.S. production could signal a diversification trend for premium device silicon, especially if trade policy pressure persists. But Intel’s ability to convert this into durable economics depends on yield and process performance, not just customer wins; a single high-profile logo does not fix the capex intensity or margin structure if ramp economics disappoint. The bigger risk is that investors extrapolate one partnership into a broad foundry turnaround before the execution proof is there.

The trade is becoming crowded in the short term after a sharp year-to-date rerating, so the best risk/reward is likely on pullbacks or via defined-risk structures rather than outright chase. Over the next few days, the stock can keep squeezing on rumor confirmation, but over the next 3-6 months the catalyst path is binary: either concrete customer commitments and guidance upgrades, or a fade once the deal is shown to be exploratory. The consensus may be underestimating how much of this move is policy-driven versus operationally earned, which raises the odds of volatility if Washington optics improve faster than Intel’s manufacturing metrics.

Key Decisions for Investors

• Hold off on adding INTC outright after the spike; instead wait for a 5-10% pullback or a failed breakout to initiate a starter long over 3-6 months, as the current setup is more headline-driven than cash-flow driven.
• Buy INTC Jan-2027 call spreads to express upside from a confirmed Apple/US manufacturing pathway while limiting downside if talks stall; structure for a 2:1 to 3:1 payoff if the stock re-rates on partner validation.
• Pair trade: long INTC / short TSM on a 1-3 month horizon if you want to express U.S. reshoring optionality; add only on confirmation of Apple-specific manufacturing language, since TSM remains the cleaner fundamental name.
• If already long INTC, trim 20-30% into strength and replace with a call spread or collar; the stock has likely pulled forward several quarters of good news and is vulnerable to rumor fatigue.
• Watch AAPL only as a hedged beneficiary: any U.S. manufacturing announcement is marginally positive, but the real trade is via supply-chain diversification sentiment rather than direct earnings impact.